Super Bowl LIX might be over, but the leftover controversies are still buzzing!This year, a Super Bowl commercial put out by the telehealth company Hims & Hers has been drawing both attention and side-eyes from critics who say the company's promotion of its weight-loss drugs misled consumers by leaving out key information.Hims & Hers, which advertised itself as a service offering inexpensive GLP-1 agonists or semaglutides the class of medications that includes Ozempic and Wegovy, is being criticized heavily
Accessibility: Our facility is fully ADA compliant, ensuring easy access for patients with mobility needs, including wheelchair ramps and accessible restrooms
N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Bioavailability of potassium from potatoes and potassium gluconate: A randomized dose response trial
